Baseline maximum standardised uptake value does not predict outcomes in high‐tumour‐burden follicular lymphoma treated with first‐line immunochemotherapy
Year: 2026
Type: article
Abstract: Baseline maximum standardised uptake value does not predict survival in high-tumour-burden follicular lymphoma treated with first-line immunochemotherapy, but identifies patients at risk of histological transformation: no transformation occurred below the cohort median. Its role is to guide biopsy and surveillance rather than therapeutic stratification.
Source: British Journal of Haematology
DOI: 10.1111/bjh.70936
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,190
OpenAlex ID: W7225154661
